» Articles » PMID: 21448283

MiR-34a in Age and Tissue Related Radio-sensitivity and Serum MiR-34a As a Novel Indicator of Radiation Injury

Overview
Journal Int J Biol Sci
Specialty Biology
Date 2011 Mar 31
PMID 21448283
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

MiR-34a, a direct target of p53, has shown to exert potent anti-proliferative effects. It has also been found that miR-34a can be induced by irradiation in vitro and in vivo. However, the relationship between miR-34a and radio-sensitivity, and its potential diagnostic significance in radiation biology, remain unclear. This study found that differing responses to ionizing radiation (IR) of young and adult mice were related to miR-34a. First, we found that miR-34a could be induced in many organs by radiation of both young and adult mice. However, the level of miR-34a induced by young mice was much higher when compared to adult mice. Next, we found that miR-34a played a critical role in radio-sensitivity variations of different tissues by enhancing cell apoptosis and decreasing cell viability. We also found that the induction of miR-34a by radiation was in a p53 dependent manner and that one possible downstream target of miR-34a that lead to different radio-sensitivity was the anti-apoptosis molecular Bcl-2. However, over-expression of miR-34a and knockdown of Bcl-2 could significantly enhance the radio-sensitivity of different cells while inhibition of miR-34a could protect cells from radiation injury. Finally, we concluded that miR-34a could be stable in serum after IR and serve as a novel indicator of radiation injury. Taken together, this data strongly suggests that miR-34a may be a novel indicator, mediator and target of radiation injury, radio-sensitivity and radioprotection.

Citing Articles

Ionizing radiation effects on blood-derived extracellular vesicles: insights into miR-34a-5p-mediated cellular responses and biomarker potential.

Huber C, Elsaeed O, Lahmer P, Moertl S Cell Commun Signal. 2024; 22(1):471.

PMID: 39358789 PMC: 11446100. DOI: 10.1186/s12964-024-01845-x.


Current Insights into Molecular Mechanisms and Potential Biomarkers for Treating Radiation-Induced Liver Damage.

Saha B, Pallatt S, Banerjee A, Banerjee A, Pathak R, Pathak S Cells. 2024; 13(18.

PMID: 39329744 PMC: 11429644. DOI: 10.3390/cells13181560.


MicroRNAs as Regulators of Radiation-Induced Oxidative Stress.

Kura B, Pavelkova P, Kalocayova B, Pobijakova M, Slezak J Curr Issues Mol Biol. 2024; 46(7):7097-7113.

PMID: 39057064 PMC: 11276491. DOI: 10.3390/cimb46070423.


Microarray analysis identifies coding and non-coding RNA markers of liver injury in whole body irradiated mice.

Aryankalayil M, Bylicky M, Martello S, Chopra S, Sproull M, May J Sci Rep. 2023; 13(1):200.

PMID: 36604457 PMC: 9814510. DOI: 10.1038/s41598-022-26784-w.


Improving the prediction for the response to radiotherapy of clinical tumor samples by using combinatorial model of MicroRNA expression.

Tang C, Qi J, Wu Y, Luo L, Wang Y, Wu Y Front Genet. 2022; 13:1069112.

PMID: 36482894 PMC: 9723130. DOI: 10.3389/fgene.2022.1069112.


References
1.
Streffer J, Rimner A, Rieger J, Naumann U, Rodemann H, Weller M . BCL-2 family proteins modulate radiosensitivity in human malignant glioma cells. J Neurooncol. 2002; 56(1):43-9. DOI: 10.1023/a:1014448721327. View

2.
Chim S, Shing T, Hung E, Leung T, Lau T, Chiu R . Detection and characterization of placental microRNAs in maternal plasma. Clin Chem. 2008; 54(3):482-90. DOI: 10.1373/clinchem.2007.097972. View

3.
Ruby J, Jan C, Bartel D . Intronic microRNA precursors that bypass Drosha processing. Nature. 2007; 448(7149):83-6. PMC: 2475599. DOI: 10.1038/nature05983. View

4.
Guo H, Ingolia N, Weissman J, Bartel D . Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010; 466(7308):835-40. PMC: 2990499. DOI: 10.1038/nature09267. View

5.
Abdulkarim B, Sabri S, Deutsch E, Chagraoui H, Maggiorella L, Thierry J . Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers. Oncogene. 2002; 21(15):2334-46. DOI: 10.1038/sj.onc.1205006. View